Skip to content

Clinical trials

Completed Phase 1/2 Carcinoma, Renal Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1/2 Status: Completed Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20024
20032
20045
20056
20065
20071
20081
20106
20111
20123
20131
20145
20153
20169
20177
20185
20204
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Fred Hutchinson Cancer Center4
Incyte Biosciences International Sàrl4
Memorial Sloan Kettering Cancer Center3
Merck Sharp & Dohme LLC3
Argos Therapeutics2
Ludwig Institute for Cancer Research2
Pfizer2
AVEO Pharmaceuticals, Inc.1
Aptose Biosciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell82
Carcinoma, Non-Small-Cell Lung19
Kidney Neoplasms17
Melanoma15
Squamous Cell Carcinoma of Head and Neck9
Breast Neoplasms8
Colorectal Neoplasms8
Ovarian Neoplasms8
Carcinoma, Hepatocellular6
Neoplasm Metastasis6

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.